HINOON

, ,

Highnoon Laboratories Limited (HINOON) – BUY Signal & Analysis

Highnoon Laboratories Limited (HINOON) has released a new market announcement. Our AI-driven analysis suggests a BUY signal with a strength of 8/10.

⚡ Flash Analysis for HINOON

Highnoon Laboratories Limited’s Annual Report for the Year Ended 31 December 2025 showcases significant financial growth, with sales increasing by 11.2% and earnings per share rising by 26.6%. The company highlights its commitment to expanding its product portfolio and strengthening stakeholder engagement.

Signal
BUY 📈
Reaction
GAP UP
Current Price
Rs. 972.90
P/E Ratio
12.51

📌 Key Investment Takeaways

  • Sales increased by 11.2% to Rs. 25.78 billion in 2025.
  • Earnings per share increased by 26.6% to Rs. 77.75 in 2025.
  • Total Assets grew by 14.6% to Rs. 18.41 billion in 2025.
  • EBITDA increased by 27.7% to Rs. 7.07 billion in 2025.
  • Profit After Tax increased by 26.6% to Rs. 4.11 billion in 2025.
  • Equity increased by 17.4% to Rs. 13.17 billion in 2025.
  • Gross Profit increased by 18.4% to Rs. 14.12 billion in 2025.
  • The company launched 17 new products in 2025, expanding its portfolio.

📊 HINOON Fundamental Snapshot

Live market data relative to this announcement:

EPS (Latest) N/A
EPS Growth 26.61%
Free Float 40.00%
YTD Change -4.85%

🎯 Investment Thesis

Highnoon Laboratories Limited reported a strong financial performance for the year ended December 31, 2025, with significant increases in key financial metrics such as sales, earnings per share, total assets, EBITDA, profit after tax, equity, and gross profit. The company’s strategic initiatives, including expanding its product portfolio and strengthening engagement with healthcare professionals, are driving growth and market acceptance. The launch of new products and focus on operational excellence position Highnoon for continued success and long-term value creation for its shareholders.

Official Source: Download PDF Announcement

Disclaimer: This analysis is AI-generated for informational purposes and does not constitute financial advice. Data source: PSX.

Written by: FoxLogica News Analysis

Published on: April 10, 2026

HINOON Stock Analysis

Highnoon Laboratories Limited (HINOON) – HOLD Signal & Analysis

Highnoon Laboratories Limited (HINOON) has released a new market announcement. Our AI-driven analysis suggests a HOLD signal with a strength of 5/10.

⚡ Flash Analysis for HINOON

Market notice for HINOON.

Signal
HOLD ⏸️
Reaction
NEUTRAL
Current Price
Rs. 920.02
P/E Ratio
11.83

📌 Key Investment Takeaways

  • See detailed PDF

📊 HINOON Fundamental Snapshot

Live market data relative to this announcement:

EPS (Latest) N/A
EPS Growth 26.61%
Free Float 40.00%
YTD Change -10.02%

🎯 Investment Thesis

Analysis unavailable.

Official Source: Download PDF Announcement

Disclaimer: This analysis is AI-generated for informational purposes and does not constitute financial advice. Data source: PSX.

Written by: FoxLogica News Analysis

Published on: April 8, 2026

Highnoon Laboratories Limited (HINOON) – BUY Signal & Analysis

Highnoon Laboratories Limited (HINOON) has released a new market announcement. Our AI-driven analysis suggests a BUY signal with a strength of 8/10.

⚡ Flash Analysis for HINOON

Highnoon Laboratories Limited has announced its financial results for the year ended December 31, 2025, recommending a substantial 500% cash dividend. The company’s revenue and profit have shown significant growth compared to the previous year, indicating a strong financial performance.

Signal
BUY 📈
Reaction
GAP UP
Current Price
Rs. 836.38
P/E Ratio
12.58

📌 Key Investment Takeaways

  • Revenue increased by 12.73% to PKR 27.71 billion in 2025 from PKR 24.64 billion in 2024.
  • Profit for the year surged by 22.14% to PKR 4.13 billion in 2025 from PKR 3.39 billion in 2024.
  • EPS rose to PKR 77.92 in 2025 from PKR 63.95 in 2024, an increase of 21.86%.
  • The company declared a significant cash dividend of 500% (PKR 50 per share).
  • Operating profit increased by 26.07% to PKR 6.29 billion in 2025 from PKR 5.00 billion in 2024.
  • The company’s financial position remains strong with total assets increasing to PKR 19.44 billion in 2025 from PKR 17.23 billion in 2024.
  • Total equity also saw a substantial increase to PKR 13.75 billion in 2025 from PKR 11.80 billion in 2024.
  • The strong financial results and generous dividend payout are positive indicators for investors.

📊 HINOON Fundamental Snapshot

Live market data relative to this announcement:

EPS (Latest) N/A
EPS Growth 35.41%
Free Float 40.00%
YTD Change -18.20%

🎯 Investment Thesis

Highnoon Laboratories Limited has demonstrated robust financial performance for the year ended December 31, 2025, marked by significant growth in revenue, profit, and earnings per share. The company’s ability to increase its top-line by over 12% while simultaneously improving profitability by over 22% underscores its operational efficiency and market strength. The declaration of a substantial 500% cash dividend is a clear signal of management’s confidence in the company’s future earnings potential and commitment to shareholder returns. Furthermore, the growth in total assets and equity indicates a healthy balance sheet and a solid foundation for future expansion. Given these positive financial indicators and shareholder-friendly policies, Highnoon Laboratories presents a compelling investment opportunity with potential for capital appreciation and attractive dividend income.

Official Source: Download PDF Announcement

Disclaimer: This analysis is AI-generated for informational purposes and does not constitute financial advice. Data source: PSX.

Written by: FoxLogica News Analysis

Published on: April 7, 2026

Highnoon Laboratories Limited (HINOON) – BUY Signal & Analysis

Highnoon Laboratories Limited (HINOON) has released a new market announcement. Our AI-driven analysis suggests a BUY signal with a strength of 7/10.

⚡ Flash Analysis for HINOON

Highnoon Laboratories Limited announced a 500% cash dividend for the year ended December 31, 2025, alongside a NIL bonus share, NIL right share, and NIL for any other entitlement. The company’s financial results show a significant increase in profit for the year.

Signal
BUY 📈
Reaction
GAP UP
Current Price
Rs. 834.01
P/E Ratio
12.55

📌 Key Investment Takeaways

  • Record date for 500% cash dividend is April 23rd, 2026.
  • Annual General Meeting (AGM) scheduled for April 30th, 2026.
  • Profit for the year significantly increased to PKR 4,119,312,634 in 2025 from PKR 3,253,500,701 in 2024.
  • Revenue also saw a substantial rise to PKR 25,789,241,526 in 2025.
  • Earnings Per Share (EPS) increased to PKR 77.75 in 2025 from PKR 61.41 in 2024.
  • The company’s financial position remains strong with total assets increasing to PKR 18,413,194,527.
  • The positive financial performance and generous dividend payout are strong indicators for investors.

📊 HINOON Fundamental Snapshot

Live market data relative to this announcement:

EPS (Latest) N/A
EPS Growth 35.41%
Free Float 40.00%
YTD Change -18.43%

🎯 Investment Thesis

Highnoon Laboratories Limited’s strong financial performance for the year ended December 31, 2025, characterized by a substantial increase in profit and revenue, coupled with a generous 500% cash dividend, presents a compelling investment opportunity. The increase in EPS and robust asset base further solidifies the company’s financial health. The declaration of a significant dividend indicates management’s confidence in the company’s future earnings potential and its commitment to returning value to shareholders. For stock traders, this positive news is likely to drive increased investor interest, potentially leading to a significant upward movement in the stock price.

Official Source: Download PDF Announcement

Disclaimer: This analysis is AI-generated for informational purposes and does not constitute financial advice. Data source: PSX.

Written by: FoxLogica News Analysis

Published on: April 7, 2026

Highnoon Laboratories Limited (HINOON) – HOLD Signal & Analysis

Highnoon Laboratories Limited (HINOON) has released a new market announcement. Our AI-driven analysis suggests a HOLD signal with a strength of 5/10.

⚡ Flash Analysis for HINOON

Market notice for HINOON.

Signal
HOLD ⏸️
Reaction
NEUTRAL
Current Price
Rs. 849.94
P/E Ratio
12.79

📌 Key Investment Takeaways

  • See detailed PDF

📊 HINOON Fundamental Snapshot

Live market data relative to this announcement:

EPS (Latest) N/A
EPS Growth 35.41%
Free Float 40.00%
YTD Change -16.88%

🎯 Investment Thesis

Analysis unavailable.

Official Source: Download PDF Announcement

Disclaimer: This analysis is AI-generated for informational purposes and does not constitute financial advice. Data source: PSX.

Written by: FoxLogica News Analysis

Published on: April 7, 2026

Highnoon Laboratories Limited (HINOON) – HOLD Signal & Analysis

Highnoon Laboratories Limited (HINOON) has released a new market announcement. Our AI-driven analysis suggests a HOLD signal with a strength of 5/10.

⚡ Flash Analysis for HINOON

Market notice for HINOON.

Signal
HOLD ⏸️
Reaction
NEUTRAL
Current Price
Rs. 850.00
P/E Ratio
12.79

📌 Key Investment Takeaways

  • See detailed PDF

📊 HINOON Fundamental Snapshot

Live market data relative to this announcement:

EPS (Latest) N/A
EPS Growth 35.41%
Free Float 40.00%
YTD Change -16.87%

🎯 Investment Thesis

Analysis unavailable.

Official Source: Download PDF Announcement

Disclaimer: This analysis is AI-generated for informational purposes and does not constitute financial advice. Data source: PSX.

Written by: FoxLogica News Analysis

Published on: April 6, 2026

HINOON Stock Analysis

Highnoon Laboratories Limited (HINOON) – HOLD Signal & Analysis

Highnoon Laboratories Limited (HINOON) has released a new market announcement. Our AI-driven analysis suggests a HOLD signal with a strength of 5/10.

⚡ Flash Analysis for HINOON

Market notice for HINOON.

Signal
HOLD ⏸️
Reaction
NEUTRAL
Current Price
Rs. 864.00
P/E Ratio
13.00

📌 Key Investment Takeaways

  • See detailed PDF

📊 HINOON Fundamental Snapshot

Live market data relative to this announcement:

EPS (Latest) N/A
EPS Growth 35.41%
Free Float 40.00%
YTD Change -15.50%

🎯 Investment Thesis

Analysis unavailable.

Official Source: Download PDF Announcement

Disclaimer: This analysis is AI-generated for informational purposes and does not constitute financial advice. Data source: PSX.

Written by: FoxLogica News Analysis

Published on: April 1, 2026

HINOON Stock Analysis

Highnoon Laboratories Limited (HINOON) – HOLD Signal & Analysis

Highnoon Laboratories Limited (HINOON) has released a new market announcement. Our AI-driven analysis suggests a HOLD signal with a strength of 5/10.

⚡ Flash Analysis for HINOON

Market notice for HINOON.

Signal
HOLD ⏸️
Reaction
NEUTRAL
Current Price
Rs. 849.04
P/E Ratio
12.78

📌 Key Investment Takeaways

  • See detailed PDF

📊 HINOON Fundamental Snapshot

Live market data relative to this announcement:

EPS (Latest) N/A
EPS Growth 35.41%
Free Float 40.00%
YTD Change -16.96%

🎯 Investment Thesis

Analysis unavailable.

Official Source: Download PDF Announcement

Disclaimer: This analysis is AI-generated for informational purposes and does not constitute financial advice. Data source: PSX.

Written by: FoxLogica News Analysis

Published on: March 30, 2026

⏸️ HINOON: HOLD Signal (5/10) – Resignation of Head of Internal Audit

⚡ Flash Summary

HINOON announced: Resignation of Head of Internal Audit. Basic analysis suggests neutral sentiment. Professional review recommended.

Signal: HOLD ⏸️
Strength: 5/10
Sentiment: NEUTRAL
Time Horizon: MEDIUM_TERM

📌 Key Takeaways

  • HINOON made announcement: Resignation of Head of Internal Audit
  • Automated analysis: HOLD signal detected
  • Signal strength: 5/10
  • This is basic analysis – manual review recommended
  • Professional CFA analysis unavailable

🎯 Investment Thesis

Basic HOLD indication for HINOON. Manual verification required.

View Original PDF

Disclaimer: AI-generated analysis. Not financial advice.

Written by: FoxLogica News Analysis

Published on: December 10, 2025

⏸️ HINOON: HOLD Signal (6/10) – Financial Results for the Quarter Ended September 30, 2025

⚡ Flash Summary

Highnoon Laboratories reported an increase in revenue and profit for the quarter ended September 30, 2025. The company’s revenue increased to PKR 6.90 billion compared to PKR 6.29 billion in the same quarter last year. Profit after tax rose to PKR 730.45 million from PKR 789.23 million. Despite the revenue and profit increase, the company declared no cash dividend, bonus shares or right shares, which may disappoint some investors.

Signal: HOLD ⏸️
Strength: 6/10
Sentiment: POSITIVE
Time Horizon: MEDIUM_TERM

📌 Key Takeaways

  • 💰 Revenue increased by 9.84% to PKR 6,903.75 million for the three months ended September 30, 2025, compared to PKR 6,285.30 million in the corresponding period of 2024.
  • 📈 Gross profit increased by 18.30% to PKR 3,771.96 million for the three months ended September 30, 2025, compared to PKR 3,188.04 million in the corresponding period of 2024.
  • 💼 Profit from operations increased by 14.98% to PKR 1,165.31 million for the three months ended September 30, 2025, compared to PKR 1,014.16 million in the corresponding period of 2024.
  • 💸 Profit before income tax and final tax increased by 13.17% to PKR 1,218.40 million for the three months ended September 30, 2025, compared to PKR 1,076.27 million in the corresponding period of 2024.
  • ✅ Earnings per share (basic and diluted) increased to PKR 13.79 for the three months ended September 30, 2025, compared to PKR 14.90 in the corresponding period of 2024.
  • 📊 For the nine months ended September 30, 2025, revenue from contracts with customers- net increased to PKR 20,303.54 million from PKR 18,323.93 million in 2024.
  • 💹 Gross profit for the nine months ended September 30, 2025, increased to PKR 11,198.36 million from PKR 9,165.28 million in 2024.
  • 📉 Profit from operations for the nine months ended September 30, 2025, increased to PKR 4,015.25 million from PKR 3,224.86 million in 2024.
  • ✔️ Profit after tax for the nine months ended September 30, 2025, increased to PKR 2,680.55 million from PKR 2,395.86 million in 2024.
  • 🧾 The company has authorized share capital of PKR 1,000,000,000 with issued, subscribed, and paid up share capital reserves of PKR 529,833,630.
  • 🏢 Total equity increased to PKR 12,356.35 million as of September 30, 2025, compared to PKR 11,795.13 million as of December 31, 2024.
  • 🏦 Total assets increased to PKR 18,054.41 million as of September 30, 2025, compared to PKR 17,230.96 million as of December 31, 2024.
  • 🚫 No cash dividend, bonus shares, or right shares were recommended by the Board of Directors for this quarter.

🎯 Investment Thesis

HOLD. Highnoon Laboratories shows positive financial performance with increased revenue and profit. However, the absence of dividends and potential market risks suggest a cautious approach. A HOLD recommendation is appropriate until further information on the company’s future plans and market conditions is available.

View Original PDF

Disclaimer: AI-generated analysis. Not financial advice.

Written by: FoxLogica News Analysis

Published on: November 7, 2025

+ More